Virtuix Holdings Inc.: Form 10-Q for the period ended Jun 30, 2026
Filed with the SEC on Aug 19, 2026 and accepted by EDGAR at Aug 19, 2026, 17:27 ET.
Management's discussion and analysis
As filed, 48,007 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto included in this Report under “Item 1. Interim Financial Statements”.
Overview and History
We believe Virtuix is a leader in AI-driven, full-body simulation for immersive entertainment, defense training, and enterprise applications. We pioneer movement in AI-generated worlds, whether imaginary or real, through the development of omni-directional treadmills that let users walk and run in 360 degrees without boundaries. Our flagship product, Omni One, represents a breakthrough in natural locomotion, enabling full freedom of movement, including crouching, kneeling, and jumping, in every direction within a small footprint. We operate a vertically integrated business across product design, manufacturing, content and simulation development, and distribution, with a focus on three key markets: consumer, enterprise, and defense.
Our earlier products, Omni Pro and Omni Arena, established our footprint in commercial entertainment. We’ve sold more than 4,000 Omni Pro systems for enterprise, installed 80 Omni Arena systems at entertainment venues in the U.S., and built an Omni Arena player base of over 500,000 players who signed up with an email address to play. Omni One, our most recent product, was designed for the home consumer and supports full freedom of movement within popular virtual reality games. We also sell a version of Omni One for enterprise markets and, in parallel, we are developing immersive training systems for the defense market, including Virtual Terrain Walk (“VTW”), an AI-driven, multi-user simulation system for mission planning and leader rehearsals.
We derive revenue through a combination of hardware sales and recurring software and service income. These include:
- Omni One hardware sales, with pricing ranging from $2,495 to $2,995.
- Omni Online subscription service ($14/month or $140/year), offering multiplayer access, esports leaderboards, and free games.
- Game sales via Omni One’s proprietary game store.
- Enterprise solutions, including Omni One Enterprise and Omni Arena systems.
- Accessory and replacement parts sales for Omni One and Omni Arena systems.
- Omni Care maintenance subscriptions for Omni Arena.
- Omniverse Credits for Omni Pro and Omni Arena gameplay (per-minute usage fees).
We target a gross margin of 40% on hardware sales of Omni One and second-hand Omni Arena systems, and 70% gross margin on Omni One Enterprise hardware sales. Recurring revenue from Omni Online, game sales, Omni Care, and Omniverse Credits provide high-margin, predictable cash flows that recur after initial hardware sales.
Since inception, we have operated at a loss, with revenues of $767,300 and $1,032,136 for the three months ended June 30, 2026 and 2025, respectively. Our net losses were $(7,170,566) and $(2,307,155) for the three months ended June 30, 2026 and 2025, respectively. We anticipate continued operating losses as we pursue market penetration and revenue growth in fiscal year 2027.
Key milestones for achieving sustainable profitability include:
- Scaling Omni One consumer sales through increased marketing and increased adoption as part of the Made for Meta program.
- Supplementing potentially high-volume Omni One consumer sales with potentially high-value defense contracts. We believe a “dual-use” strategy of building consumer sales plus defense contracts can position us for achieving revenue growth and sustainable profitability.
Our technology is getting early traction in the defense market. Over the last year, we sold Omni One test units to the U.S. Marine Corps, the U.S. Air Force Academy, the U.S. Military Academy at West Point, and the Air National Guard. We also got selected for Phase 1 SBIR Funding by the U.S. Air Force to advance the development of VTW, we got assigned to be the lead integrator on the development of a virtual infantry training system by the U.S. Marine Corps Training and Education Command (TECOM), we signed a development agreement with the U.S. Navy, and we integrated Omni One in a Counter-UAS training system developed for evaluation by the U.S. Marine Corps. However, we expect that meaningful sales in the defense sector may not materialize until fiscal year 2028 at the earliest. Despite the long sales cycle for penetrating the defense market, we believe that our simulation systems will retain a strong competitive moat because of our expansive omni-directional treadmill patent portfolio, our position as a U.S. company, and the inherent barriers to entry for defense applications that competitors will face, including multi-year procurement cycles and high switching costs. To sell to defense customers, we will need to comply with certain requirements and regulations to qualify for government contracts or awards, depending on the type of contract or award, including but not limited to compliance with the FAR and DFARS, Export Administration Regulations, cybersecurity regulations, and requirements and restrictions related to the secure sourcing of components, including the Buy American Act and Berry Amendment. For additional information, see “Risk Factors — Our business with governmental entities will be subject to the policies, priorities, regulations, mandates and funding levels of such governmental entities and may be negatively or positively impacted by any change thereto” of our Prospectus dated January 26, 2026.
Following our shift in R&D and marketing efforts to Omni One, and the shift in demand for entertainment attractions from staffed VR attractions such as Omni Arena to unstaffed, lower-tech offerings, we consider the Omni Arena business to be in sustaining mode. We no longer produce new systems or invest in new games or software upgrades for the system, but we continue to support our existing Omni Arena operators and earn recurring revenues from Omni Care maintenance contracts, Omniverse Credits sales, and the sale of repair and replacement parts. We also facilitate secondary market sales of Omni Arena systems and earn a target gross margin of approximately 40% on revenues earned from reselling second-hand systems and disassembling, moving, and installing such systems.
Our path to profitability relies on scaling Omni One sales at an acceptable customer acquisition cost and on gaining adoption in the defense sector. Although we believe that our plans are realistic, there is no guarantee that we will be able to scale Omni One sales or find product-market fit in the defense sector.
We believe Virtuix is at the leading edge of immersive entertainment, enterprise training, defense simulation, and the development of hyper-realistic digital twins of the real world through Gaussian splatting and other AI-driven 3D reconstruction technologies. In a world where AI is used to rapidly generate realistic virtual environments, whether imaginary game worlds or digital twins of the real world, we pioneer the technology and products for physically moving around in these virtual environments. We believe we are positioned to help define the next decade of XR advancements and be a leader in immersive gaming and simulation.
Factors Affecting our Business and Results of Operations
This section includes a summary of our historical results of operations, including detailed comparisons of our results for the three months ended June 30, 2026 and 2025. We have derived the three month data from our financial statements included elsewhere in this Report.
Results of Operations
Comparison of the Three Months Ended June 30, 2026 and 2025
Revenues
Sales for the three months ended June 30, 2026, were $767,300, a 26% decrease from sales of $1,032,136 for the three months ended June 30, 2025. This decrease is primarily attributable to the fulfillment of the final batch of the large backlog of Omni One orders accumulated since the start of the preorder period in August 2023, during the three months ended June 30, 2025, whereas revenues in the three months ended June 30, 2026 resulted from sales to newly acquired customers. New orders for Omni One systems increased 72% in the three months ended June 30, 2026 compared to unit orders placed in the three months ended June 30, 2025. Following the launch of Omni One for Quest in June 2026, new orders for Omni One systems increased by a factor of 2.5x compared to the same period last year.
The following table summarizes our revenue by product line:
| SALES | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Omni Pro units and accessories | $19,444 | $15,191 |
| Omniverse Credits | 26,959 | 45,100 |
| Omni Care program | 41,333 | 48,667 |
| Omni Arena | 157,173 | 101,266 |
| Omni One, net of discounts | 522,391 | 821,912 |
| TOTAL SALES | $767,300 | $1,032,136 |
Cost of Goods Sold
Cost of goods sold primarily consists of material costs and shipping costs of Omni One and Omni Arena.
Cost of goods sold in the three months ended June 30, 2026 was $540,142, a decrease of $315,917 from cost of goods sold of $856,059 in the three months ended June 30, 2025. The decrease was primarily attributable to lower revenues during the current period compared to the prior period that included shipments of a large backlog of Omni One preorders.
Gross profit in the three months ended June 30, 2026 was $227,158, an increase of $51,081, or 29%, compared to gross profit of $176,077 in the three months ended June 30, 2025. Gross margin as a percentage of revenues increased to 30% in the three months ended June 30, 2026 from 17% in the three months ended June 30, 2025. Omni One revenue in the three months ended June 30, 2025 included deliveries of prepaid units sold at a lower price point in prior quarters.
Operating Expenses
Operating expenses consist of general and administrative expenses, which are primarily salaries, professional fees, and expenses related to investor relations and the administrative functions of the Company, research and development expenses, which consist primarily of product development costs and salaries, and sales and marketing expenses, which represent advertising and other marketing costs, as well as the associated personnel costs.
| Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | |
|---|---|---|
| Selling Expenses | $738,978 | $1,049,658 |
| General & Administrative | 3,080,778 | 959,392 |
| Research & Development | 309,375 | 208,716 |
| Total Operating Expenses | $4,129,131 | $2,217,766 |
Total operating expenses increased to $4,129,131 in the three months ended June 30, 2026, from $2,217,766 in the three months ended June 30, 2025.
- Selling Expenses: For the three months ended June 30, 2026 compared to the same period in 2025, Selling Expenses decreased to $738,978 from $1,049,658. The higher expense in the 2025 period was largely driven by the significant digital ad spend for our Regulation Crowdfunding (“Reg CF”) investment campaign with StartEngine that ended around the end of June 2025.
- General and Administrative Expenses: For the three months ended June 30, 2026 compared to the same period in 2025, General and Administrative Expenses increased to $3,080,778 from $959,392. The increase was primarily attributable to expenses associated with operating as a publicly traded company since our public listing in January 2026. Professional services, such as legal, accounting, investor relations, and other professional services, increased by $1,236,175 for the 2026 period compared to the same period in 2025. Insurance expenses increased by $150,833 for the 2026 period compared to the same period in 2025. Employee stock compensation expense, a non-cash expense, increased by $608,960 for the 2026 period as a result of RSUs granted under the 2025 Omnibus Incentive Plan.
- Research and Development: For the three months ended June 30, 2026 compared to the same period in 2025, Research and Development expenses increased to $309,375 from $208,716. This increase was due to an increase in staffing and salaries to advance Omni One for Quest and other projects in development.
Other Expense
For the three months ended June 30, 2026, Other Expense totaled $3,219,202, primarily driven by interest expense of $2,539,592, including $2,052,255 of non-cash amortization of debt discount related to the Company’s financing arrangements, $584,150 of non-cash financing expenses recognized in connection with amendments to certain outstanding warrants, and $431,224 of non-cash loss on debt extinguishment, consisting primarily of the loss recognized in connection with the May 22 exchange of the secured convertible promissory notes for PPP #2 and losses recognized in connection with Exchange Note limited redemptions during the quarter, These were partially offset by $349,128 of non-cash gain on change in fair value of PPP #1 derivative liability. For the three months ended June 30, 2025, Other Expense totaled $241,978, primarily comprised of interest expense and loss on extinguishment of debt.
Net Loss
As a result of the foregoing, net loss for the three months ended June 30, 2026 was $(7,170,566) compared to $(2,307,155) for the three months ended June 30, 2025, representing an increase in net loss of $4,863,411. Although gross profit increased during the 2026 period, the improvement in gross profit was offset by higher non-cash expenses such as amortization of debt discount, warrant modification expenses, loss on debt extinguishment, and stock compensation expenses, as well as higher professional services expenses related to operating as a publicly traded company, resulting in a higher net loss despite underlying improvement in gross profitability.
Non-GAAP Financial Measures
Management reviews a variety of operational and financial metrics to assess the Company’s performance, allocate resources, and inform strategic decision-making. In addition to net sales, net loss, and other measures prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), this report includes certain operating metrics and non-GAAP financial measures that management considers meaningful in evaluating the Company’s operating performance.
These measures are used by management and the Board of Directors to assess trends in the business, evaluate the effectiveness of operational initiatives, and support decisions regarding investment and cost management. Management believes that the presentation of these non-GAAP financial measures provides investors with additional insight into the Company’s operating results and facilitates period-to-period comparisons.
Adjusted EBITDA
(Unaudited)
| Reconciliation of GAAP net loss to Adjusted EBITDA | For the Three Months Ended June 30, 2026 | 2025 |
|---|---|---|
| NET LOSS | $(7,170,566) | $(2,307,155) |
| Plus: | ||
| Taxes | 49,391 | 23,418 |
| Interest expense, net(1) | 2,539,429 | 119,114 |
| Depreciation and amortization | 142,953 | 158,776 |
| EBITDA | $(4,438,793) | $(2,005,847) |
| Plus: | ||
| Stock-based compensation(2) | 722,937 | 10,897 |
| Financing expense(3) | 584,150 | 0 |
| Loss on extinguishment of debt | 431,224 | 122,864 |
| Less: | ||
| Change in fair value of financial instruments | (372,350) | 0 |
| ADJUSTED EBITDA | $(3,072,832) | $(1,872,086) |
1. Interest expense for the three months ended June 30, 2026 includes $2,052,255 of non-cash amortization of debt discount related to the Company’s financing arrangements with Streeterville Capital, LLC (see Note 8 – Notes Payable to the Consolidated Financial Statements). The debt discount results from the issuance of warrants as well, original issue discounts, related closing costs, and embedded derivative bifurcation, which are being amortized to interest expense over the term of the notes.
2. Stock-based compensation expense for the three months ended June 30, 2026 consisted of non-cash expenses of $103,080 related to equity awards granted to vendors and service providers and $619,857 related to equity awards granted to employees, officers, and directors. Stock-based compensation expense for the three months ended June 30, 2025 consisted entirely of employee, officer, and director awards.
3. Financing expense represents a non-cash charge recognized in connection with amendments to certain outstanding warrants during the three months ended June 30, 2026.
Adjusted EBITDA is a non-GAAP financial measure that we use to evaluate our operating performance. Adjusted EBITDA represents net income (loss), adjusted to exclude: (i) provision for (benefit from) income taxes, (ii) interest expense, net, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) financing expense, (vi) loss on extinguishment of debt, and (vii) gains or losses from changes in the fair value of financial instruments.
We believe Adjusted EBITDA is useful to investors because it provides a supplemental measure of our operating performance by excluding non-cash expenses and other items that may not be indicative of our core operating results or that may vary significantly from period to period. For the periods presented, such non-cash items include amortization of debt discount, depreciation and amortization, stock-based compensation expense, and changes in the fair value of financial instruments, which can significantly impact reported net loss but does not impact our cash flow. However, Adjusted EBITDA has limitations and should not be considered in isolation or as a substitute for financial information prepared in accordance with GAAP. These limitations include the following:
- Stock-based compensation has been, and is expected to continue to be, a significant recurring expense and an important component of our compensation strategy.
- Depreciation and amortization relate to assets that may require replacement in the future, and Adjusted EBITDA does not reflect the cash requirements for capital expenditures.
- Adjusted EBITDA does not reflect changes in working capital or the cash requirements necessary to service our debt.
- Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently, limiting their usefulness as comparative measures.
Accordingly, Adjusted EBITDA should be considered only as a supplement to, and not as a substitute for, net income (loss) and other measures prepared in accordance with GAAP.
Liquidity and Capital Resources
We continue to experience negative cash flows from operations as we expand our business. Our cash flows from operating activities are significantly affected by our cash investments to support the growth of our business in areas such as sales and marketing, product development, and general and administrative. Our operating cash flows are also affected by our working capital needs to support the scaling of manufacturing and inventories.
As of June 30, 2026 and March 31, 2026, the Company had cash on hand of $7,443,869 and $9,471,288, respectively. Since its inception, the Company has incurred net losses and funded its operations primarily through the issuance of equity securities. As of June 30, 2026 and March 31, 2026, the Company had a total stockholders’ deficit of $(3,080,495) and a total stockholders’ equity of $1,096,752, respectively. The Company has incurred recurring losses from operations, and as of June 30, 2026 and March 31, 2026, had an accumulated deficit of $(86,517,001) and $(79,346,435), respectively.
The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. The Company has developed plans to raise funds and continues to pursue sources of funding that management believes, if successful, would be sufficient to support the Company’s operation and growth. As discussed in the Subsequent Events section of the Notes to the Consolidated Financial Statements, the Company has successfully executed sources of funding and debt conversions in July 2026. Streeterville has exercised 455,500 warrants during this period, resulting in proceeds to the Company of $1,181,250. Additionally, outstanding notes with a principal amount of $67,389 were converted to shares of the Company’s Class A common stock.
During the three months ended June 30, 2026, the Company raised the following proceeds from financing activities:
- $1,380,000 through the exercise of warrants, pursuant to which Virtuix issued 230,000 shares of Class A common stock.
On January 27, 2026, in connection with the closing of the Company’s direct listing, Streeterville funded the initial pre-paid purchase under the Equity Purchase Agreement. The Company received $8,000,000 in cash proceeds, net of an 8% original issue discount, and the pre-paid purchase had an original principal balance of $8,640,000 (“PPP #1”). PPP #1 bears interest at a rate of 6% per annum and has no stated maturity date.
On May 22, 2026, the Company and Streeterville exchanged the outstanding First Note, Second Note and Third Note, including accrued interest thereon, for a second pre-paid purchase under the Equity Purchase Agreement (“PPP #2”). PPP #2 had an original principal balance of $3,471,923. The exchange did not provide the Company with additional cash proceeds. As a result of the exchange, the Streeterville Notes were extinguished, and no amounts remained outstanding under those notes as of June 30, 2026.
PPP #2 bears interest at a rate of 6% per annum and contains terms substantially consistent with those of PPP #1, including Streeterville’s ability to apply outstanding amounts toward the purchase of shares of the Company’s Class A common stock in accordance with the applicable agreement. The Company may prepay all or a portion of the outstanding balance of each pre-paid purchase, subject to specified prepayment premiums. The agreements also contain customary events of default, ownership limitations and other Company covenants.
During the three months ended June 30, 2026, Streeterville delivered limited redemption notices under the Exchange Note with an aggregate redemption amount of $284,500. The Company settled the limited redemptions through the issuance of an aggregate of 93,333 shares of Class A common stock. The settlements were non-cash financing transactions and did not provide the Company with additional liquidity. As of June 30, 2026, the Exchange Note had an outstanding principal balance of approximately $2,422,664.
Under the Equity Purchase Agreement, Streeterville committed to purchase up to an aggregate of $50,000,000 of the Company’s Class A common stock through one or more pre-paid purchases over a 24-month period. The Company’s ability to obtain additional advances is subject to several conditions, including minimum market-capitalization and trading-volume requirements, continued compliance with Nasdaq listing standards and the effectiveness of an applicable resale registration statement. Accordingly, Streeterville’s obligation to fund additional advances is not solely within the Company’s control, and there can be no assurance that the Company will be able to access the full amount, or any particular amount, remaining under the Equity Purchase Agreement. For additional information, see “Risk Factors — Our pre-paid purchase arrangements with Streeterville may result in substantial dilution and, if our stock price is below the $2.00 Floor Price for six consecutive months, could require cash payments that adversely affect our liquidity” in Part II, Item 1A of this Quarterly Report on Form 10-Q.
See Note 8, Notes Payable, to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding PPP #1, PPP #2, the Exchange Note and the Equity Purchase Agreement.
As of June 30, 2026, our current obligations include the Exchange Note issued to Streeterville Capital, LLC, with a principal amount of $2,422,664 maturing in July 2027, an EIDL loan with a carrying amount of approximately $24,000 maturing in August 2050, a PPP advance with Streeterville Capital, LLC, with an original principal balance of $8,640,000, accrued interest of $224,611, and no stated maturity date, a second PPP advance with Streeterville Capital, LLC, with an original principal balance of $3,471,923, accrued interest of $23,222, and no stated maturity date, current operating lease obligations totaling approximately $256,966, and outstanding gift card liabilities of approximately $446,000.
We anticipate incurring additional losses for the foreseeable future, and we may never become profitable.
As of the date of this filing, following proceeds from Streeterville warrant exercises in July 2026, the Company believes its existing cash resources will be sufficient to fund its planned operations in the near term. However, to continue as a going concern and execute its operating plan over the next 12 months, the Company will need to obtain additional financing. The timing and amount of additional financing required will depend on a number of factors, including the Company’s operating performance, cash expenditures and the timing and amount of any additional financing activities.
Our operating plan is predicated on a variety of assumptions including, but not limited to, the level of product demand, cost estimates, our ability to continue to raise additional financing and the state of the general economic environment in which we operate. There can be no assurance that these assumptions will prove accurate in all material respects, or that we will be able to successfully execute our operating plan. In the absence of additional appropriate financing, we may have to modify our plan or slow down the pace of development and commercialization.
The following table summarizes our cash flows from operating, investing, and financing activities for the three months ended June 30, 2026 and June 30, 2025:
| Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | |
|---|---|---|
| Net cash used in operating activities | $(3,294,829) | $(1,491,122) |
| Net cash used by investing activities | $(11,247) | $(3,496) |
| Net cash provided by financing activities | $1,278,657 | $1,600,504 |
36
Tariffs
Our products are currently manufactured primarily in China and imported into the United States. U.S. import tariff rates have fluctuated significantly in recent years and have the potential to materially impact our financial results by reducing our profit margins or requiring us to raise consumer selling prices, which could in turn depress demand. We consider the materiality threshold to be any tariff level that exceeds 30% and remains elevated for a sustained period. For additional information, see “Risk Factors — Unfavorable global economic and political conditions, including tariffs and trade barriers, could adversely affect our business, financial condition or results of operations” of our Prospectus dated January 26, 2026.
On February 20, 2026, the U.S. Supreme Court ruled against tariffs imposed by the Trump administration under the International Emergency Economic Powers Act (IEEPA). Following this ruling, the administration imposed a new 10% global tariff under Section 122 of the Trade Act of 1974, effective February 24, 2026. Section 122 tariffs are limited by statute to 150 days without congressional extension and expired on July 24, 2026. In May 2026, the U.S. Court of International Trade found the Section 122 tariffs unlawful, although this ruling was stayed pending appeal and the tariffs remained in effect through their expiration. The Company paid IEEPA tariffs on its imports during the period in which such tariffs were in effect and has submitted refund claims to U.S. Customs and Border Protection. The amounts involved are not material to the Company’s condensed consolidated financial statements.
Effective July 24, 2026, the administration imposed additional tariffs under Section 301 of the Trade Act of 1974. These tariffs currently apply to imports from approximately 60 countries at rates ranging from 10% to 12.5%.
While the near-term tariff environment remains difficult to predict, and the duration, scope, and legal validity of currently imposed tariffs remain uncertain, the Company believes it is well positioned to manage a range of potential outcomes.
As detailed in our Prospectus, we have mitigated the potential impact of high tariffs on China-made goods by developing Taiwan as an alternative manufacturing location. In February 2026, the United States and Taiwan signed the U.S.-Taiwan Agreement on Reciprocal Trade, which caps the U.S. reciprocal tariff rate on Taiwanese goods at no more than 15%. This agreement is subject to legislative approval in Taiwan. Following the expiration of the Section 122 tariffs on July 24, 2026, Section 301 tariffs of 10% to 12.5% currently apply to imports from Taiwan. Future actions or modifications through Section 301 and other tariff-related measures could result in additional or different tariff rates on Taiwanese goods. Accordingly, the ultimate tariff treatment of Taiwanese goods remains subject to significant legal and policy uncertainty.
In January 2023, we opened a wholly owned Taiwan subsidiary named Virtuix Manufacturing Taiwan Ltd. and began outsourcing some Omni One materials to Taiwanese factories. If import tariffs on goods from China were to exceed the materiality threshold for a sustained period, we can expand our Taiwan manufacturing program by assembling the entire Omni One product in Taiwan. There can be no assurance, however, that tariff mitigation strategies, including geographic diversification, will fully offset the impact of new or increased tariffs, or that the current tariff framework applicable to Taiwanese goods will remain in effect.
Emerging Growth Company
We are an “emerging growth company,” as defined in the JumpStart Our Business Startups Act of 2012 (“JOBS Act”). The status of “emerging growth company” enables us to invest more in research & development and customer acquisition rather than compliance overhead. As an emerging growth company, we are eligible to take advantage of certain exemptions from various reporting and disclosure requirements that are applicable to public companies that are not emerging growth companies, and we have elected to take advantage of those exemptions. For so long as we remain an emerging growth company, we will not be required to:
- have an auditor attestation report on our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);
- submit certain executive compensation matters to shareholder advisory votes pursuant to the “say on frequency” and “say on pay” provisions (requiring a non-binding shareholder vote to approve compensation of certain executive officers) and the “say on golden parachute” provisions (requiring a non-binding shareholder vote to approve golden parachute arrangements for certain executive officers in connection with mergers and certain other business combinations) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010; or
- disclose certain executive compensation related items, such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation.
In addition, the JOBS Act provides that an emerging growth company may take advantage of an extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. This means that an emerging growth company can delay adopting certain accounting standards until such standards are otherwise applicable to private companies. We have elected to take advantage of the extended transition period. Since we will not be required to comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies, our financial statements may not be comparable to the financial statements of companies that comply with public company effective dates. If we were to subsequently elect to comply with these public company effective dates, such election would be irrevocable pursuant to Section 107 of the JOBS Act.
We will remain an emerging growth company for up to five years, or until the earliest of: (i) the last date of the fiscal year during which we had total annual gross revenues of $1.235 billion or more; (ii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or (iii) the date on which we are deemed to be a “large accelerated filer” as defined under Rule 12b-2 under the Exchange Act.
We do not believe that being an emerging growth company will have a significant impact on our business. Also, even once we are no longer an emerging growth company, we still may not be subject to auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act unless we meet the definition of a large accelerated filer.
Critical Accounting Policies and Estimates
The preparation of our condensed consolidated financial statements in accordance with U.S. GAAP requires management to apply accounting policies and make estimates, assumptions and judgments that affect the amounts reported in our financial statements and accompanying notes. We consider accounting policies and estimates to be critical when their application requires significant judgment or involves a significant level of estimation uncertainty and when changes in those judgments, assumptions or estimates have had, or are reasonably likely to have, a material effect on our financial condition or results of operations.
Management bases its estimates and judgments on historical experience, current conditions, contractual terms, available market information and other factors that management believes to be reasonable under the circumstances. Because estimates and judgments involve inherent uncertainty, actual results may differ from those estimates. The critical accounting policies and estimates discussed below should be read in conjunction with the significant accounting policies described in Note 2 to our condensed consolidated financial statements.
Except as described below, there have been no material changes to our critical accounting policies and estimates since March 31, 2026.
Revenue Recognition
We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. The application of ASC 606 requires management to make judgments regarding the identification of performance obligations, the timing of the transfer of control of products and services to customers and, for arrangements containing multiple performance obligations, the allocation of the transaction price based on relative standalone selling prices.
Revenue from our hardware products is generally recognized upon shipment or installation, depending on when control transfers to the customer. Revenue associated with service and support arrangements, including Omni Care, Omni Online and extended warranties, is recognized over the applicable service period. Revenue from Omniverse credits is recognized over the estimated period in which the credits are expected to be consumed based on customer usage patterns. For arrangements containing multiple performance obligations, we use observable standalone selling prices when available to allocate consideration among the respective performance obligations. Changes in estimates or judgments regarding the timing of satisfaction of performance obligations, customer usage patterns or allocation of consideration could affect the timing and amount of revenue recognized. See Note 2 to our condensed consolidated financial statements for additional information regarding our revenue recognition policies.
Fair Value of Complex Financing Instruments
During the three months ended June 30, 2026, the Company corrected its analysis of certain financing arrangements, including its pre-paid purchase arrangements with Streeterville Capital, LLC and related debt and equity-linked features. As a result, certain embedded features are accounted for separately and measured at fair value, and certain financing instruments are measured in their entirety at fair value pursuant to the fair value option. The additional analysis also resulted in revisions to the accounting for certain previously reported amounts. Accordingly, the determination of fair value for these financing instruments and related features represents a critical accounting estimate for the current period. See Note 8 to the condensed consolidated financial statements for additional information regarding the Company’s financing arrangements.
The Company estimates the fair value of these instruments and features using valuation techniques appropriate to the specific contractual terms and economic characteristics of each instrument. These techniques may include option-pricing methodologies, discounted cash flow analyses and probability-weighted scenario analyses. The valuations incorporate observable market information when available as well as significant assumptions for which directly observable market information may not be available.
Depending on the instrument or feature being valued, significant inputs and assumptions may include the market price of the Company’s Class A common stock, expected stock-price volatility, risk-free interest rates, expected term or settlement period, market yields or discount rates, and the probability and expected timing of conversion, prepayment, redemption, trigger events and other contractual settlement outcomes. The valuations also consider applicable contractual provisions, including floor prices, prepayment premiums, ownership limitations and other settlement provisions that may affect the amount or timing of expected cash or equity settlement.
Management develops these assumptions based on the facts and circumstances existing at each measurement date, including available market data, the contractual terms of the instruments, the Company’s historical experience, current liquidity and financing circumstances, and other contemporaneous information relevant to the probability and expected timing of potential settlement outcomes. Certain of these assumptions require significant judgment, particularly where a contractual outcome is dependent on future market conditions, financing activity or actions that may be taken by the Company or the counterparty.
The estimated fair values of these instruments and features may be sensitive to changes in the underlying assumptions. Changes in the Company’s stock price or expected volatility, market interest rates or discount rates, or the estimated probability or timing of conversion, prepayment or other contractual outcomes could result in materially different fair value measurements. As a result, changes in these estimates may materially affect the carrying amounts of the related financing instruments and derivative liabilities and the related gains, losses or other amounts recognized in the Company’s condensed consolidated financial statements.
Management reassesses the assumptions used in these valuations at each required measurement date. Because the ultimate timing and manner of settlement may differ from the assumptions used in the valuation models, actual results may differ materially from the amounts estimated, and the fair value of these instruments and features may fluctuate significantly from period to period. Certain of these fair value measurements utilize significant unobservable inputs and, accordingly, are classified within Level 3 of the fair value hierarchy.
Quantitative and Qualitative Disclosures About Market Risk
We have not utilized any derivative financial instruments for hedging purposes such as futures contracts, options and swaps, forward foreign exchange contracts or interest rate swaps and futures. We believe that adequate controls are in place to monitor any hedging activities, if they were to occur in the future. We do not intend to hedge any existing or future borrowings and, consequently, we do not expect to be affected by changes in market interest rates. We do currently have sales and own assets and operate facilities in countries outside the United States and, consequently, we may be affected by foreign currency fluctuations or exchange rate changes.
Recent Accounting Pronouncements
On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) — Improvements to Income Tax Disclosures, which enhances transparency regarding income tax disclosures, primarily through additional information regarding the income tax rate reconciliation and income taxes paid by jurisdiction. The Company adopted ASU 2023-09 effective April 1, 2026. The amendments are applied prospectively, with retrospective application permitted. Because the amendments relate solely to disclosures, adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows. The Company is currently evaluating the impact of the ASU on its annual income tax disclosures, which will first be reflected in the Company’s financial statements for the fiscal year ending March 31, 2027.
In March 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income (Subtopic 220-40): Expense Disaggregation Disclosures. The ASU requires public business entities to disclose in a tabular format significant expense categories that are included in each relevant income statement line item. The standard is effective for fiscal years beginning after December 15, 2026, including interim periods within those years. Early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures.
Management has reviewed other recently issued but not yet effective accounting standards and believes they will not have a material impact on the Company’s consolidated financial statements. The Company will adopt applicable standards as required.
Off-Balance Sheet Arrangements
We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.
Internal Control Over Financial Reporting
Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. Under standards established by the Public Company Accounting Oversight Board, or PCAOB, a deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or personnel, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. The PCAOB defines a material weakness as a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.
During the preparation of the Company’s condensed consolidated financial statements for the three months ended June 30, 2026, management identified a material weakness in the Company’s internal control over financial reporting related to the accounting for complex financing transactions. This material weakness existed as of March 31, 2026 and continued to exist as of June 30, 2026. The material weakness is separate from the material weaknesses previously disclosed by the Company, which management concluded had been remediated as of March 31, 2026.
Management identified a material weakness in the Company’s internal control over financial reporting related to the accounting for complex financing transactions. Specifically, the Company did not maintain effective controls designed to identify, evaluate, and document the application of U.S. GAAP to debt and other financing arrangements containing potentially complex terms and embedded features. As a result, management did not perform a timely technical accounting assessment of certain debt instruments to determine whether embedded features required bifurcation and separate accounting as derivative liabilities. This control deficiency resulted in errors in the Company’s accounting for certain financing arrangements and required adjustments and revision to prior period financial information to record embedded derivative liabilities and related accounting impacts.
Although management concluded that the identified control deficiency constituted a material weakness because there was a reasonable possibility that it could result in a material misstatement that would not be prevented or detected on a timely basis, management separately evaluated the actual errors resulting from the deficiency and concluded that those errors, individually and in the aggregate, were not material to the Company’s previously issued financial statements.
Management has begun implementing remediation measures designed to strengthen the Company’s internal control over financial reporting with respect to complex and non-routine financing transactions. These measures include enhancing procedures for identifying transactions requiring technical accounting analysis, implementing formal and documented reviews of significant contractual terms and embedded features, enhancing review and approval by personnel with appropriate technical accounting expertise, and utilizing third-party technical accounting and valuation specialists when appropriate.
Management will continue to evaluate and enhance these controls as necessary. The material weakness will not be considered remediated until the applicable controls have been implemented, have operated for a sufficient period of time and management has concluded, through testing, that the controls are operating effectively. See Part I, Item 4, “Controls and Procedures,” for additional information regarding the material weakness and the Company’s disclosure controls and procedures.
Market risk
As filed, 163 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.
Controls and procedures
As filed, 2,731 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2026. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2026 due to the material weakness in internal control over financial reporting described below.
Material Weakness and Remediation
During the preparation of our condensed consolidated financial statements for the three months ended June 30, 2026, management identified a material weakness in internal control over financial reporting related to the accounting for complex financing transactions. Specifically, the Company did not maintain controls designed at a sufficient level of precision to timely identify, evaluate and document the application of U.S. GAAP to debt and other financing arrangements containing complex contractual terms and embedded features. This material weakness existed as of March 31, 2026 and continued to exist as of June 30, 2026. See “Internal Control Over Financial Reporting” in Part I, Item 2 of this Quarterly Report for a description of the material weakness and management’s remediation efforts.
Changes in Internal Control over Financial Reporting
Other than the identification of the material weakness described above, which reflected a deficiency in controls that existed as of March 31, 2026 and continued through June 30, 2026 and therefore did not constitute a change in ICFR during the quarter, there were no changes in our internal control over financial reporting during the quarter ended June 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Subsequent to June 30, 2026, management began implementing the remediation measures described above.
Risk factors
As filed, 5,641 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations carefully consider the factors discussed in “Risk Factors” of our Prospectus dated January 26, 2026, which could materially affect our business, financial condition or future results. Other than as set forth below, we have identified no material changes from the risk factors previously disclosed in the Prospectus.
We have identified a material weakness in our internal control over financial reporting related to the accounting for complex financing transactions, and our failure to remediate this material weakness or otherwise maintain effective internal controls could adversely affect our financial reporting and investor confidence.
During the preparation of our condensed consolidated financial statements for the three months ended June 30, 2026, management identified a material weakness in our internal control over financial reporting related to the accounting for complex financing transactions. Specifically, the Company did not maintain effective controls designed to identify, evaluate, and document the application of U.S. GAAP to debt and other financing arrangements containing potentially complex terms and embedded features. As a result, management did not perform a timely technical accounting assessment of certain debt instruments to determine whether embedded features required bifurcation and separate accounting as derivative liabilities. This control deficiency resulted in errors in the Company's accounting for certain financing arrangements and required adjustments and revision to prior period financial information to record embedded derivative liabilities and related accounting impacts.
This material weakness existed as of March 31, 2026 and continued to exist as of June 30, 2026, and resulted in errors in the accounting for certain financing arrangements that required revisions to previously reported financial information.
We have begun implementing remediation measures designed to strengthen our controls over complex and non-routine financing transactions, including enhanced procedures for identifying transactions requiring technical accounting analysis, documented review of significant contractual terms and embedded features, and the use of qualified technical accounting and valuation resources, including third-party specialists when appropriate. However, we cannot provide assurance that these measures will successfully remediate the material weakness or that additional material weaknesses or significant deficiencies will not be identified in the future. Management, under the oversight of the Audit Committee, is monitoring the implementation and effectiveness of these remediation measures.
Until this material weakness is remediated, there is a reasonable possibility that a material misstatement of our annual or interim financial statements may not be prevented or detected on a timely basis. If we are unable to remediate this material weakness or otherwise maintain effective internal control over financial reporting and disclosure controls and procedures, we could experience additional errors in our financial reporting, be required to revise or restate our financial statements, experience delays in meeting our reporting obligations, incur additional costs associated with remediation and compliance efforts, and experience reduced investor confidence in our financial reporting, any of which could adversely affect the market price of our Class A common stock.
Our pre-paid purchase arrangements with Streeterville may result in substantial dilution and, if our stock price is below the $2.00 Floor Price for six consecutive months, could require cash payments that adversely affect our liquidity.
As previously disclosed, we entered into an Equity Purchase Agreement with Streeterville Capital, LLC (“Streeterville”) under which Streeterville committed to purchase up to $50,000,000 of our Class A common stock through one or more pre-paid advances. On May 22, 2026, we entered into a second pre-paid purchase with Streeterville in exchange for our outstanding secured convertible promissory notes held by Streeterville. Under the pre-paid purchases, if specified trigger events occur, the share purchase price may be based on a market-price formula tied to 90% of the lowest volume-weighted average price of our Class A common stock during the applicable ten-trading-day measurement period. Because our Class A common stock has recently traded below $2.00 per share, issuances under this formula could require us to issue a substantially greater number of shares to satisfy a given portion of the outstanding pre-paid purchase balance, which could result in substantial dilution to existing stockholders and place downward pressure on the market price of our Class A common stock.
The pre-paid purchases also define a $2.00 floor price (the “Floor Price”). The Floor Price does not operate as a fixed minimum price at which shares may be issued in all circumstances. However, if the applicable share purchase price remains below the Floor Price for at least six consecutive months, Streeterville may elect to have the applicable purchase amount paid in cash rather than shares of Class A common stock. Any such cash payment requirement, or any default arising from our inability to deliver shares or comply with the pre-paid purchase documents, could materially and adversely affect our liquidity, financial condition and ability to continue executing our business strategy.
Source: SEC EDGAR, the filing index for accession 0001213900-26-091795. Last ingested by Listed: Nov 12, 2026, 19:50 ET. Listed shows no prices and gives no investment advice.